The Ardent Health shareholder alert hides a deeper story: the fragility of PE-backed hospital empires facing market scrutiny. This isn't just about ARDT stock.
New Zealand's push for heart checks this Valentine's Day masks systemic failures in preventative health and the true cost of cardiovascular disease.
Behind the headlines of Children's Health Ireland's spinal care reviews lies a systemic failure. We dissect the true fallout of these delays in paediatric spinal care.
AstraZeneca is banking on sustained **oncology demand** through 2026, but this isn't just about drugs; it's about market control and the future of **pharma technology** investment.
Asia's massive healthcare gap demands funding, but the call for 'patient capital' signals a dangerous privatization trend.
The WHO pushes for child-friendly public spaces, but who is footing the bill for this massive urban health overhaul? Analyzing the hidden costs.